评价低甲基化药物格来他滨联合卡铂在广泛期小细胞肺癌中的疗效和安全性的 II 期试验的简要报告。
关键词: Epigenetic modification Platinum resistance Relapsed small cell lung cancer
Mesh : Humans Carboplatin / therapeutic use Small Cell Lung Carcinoma / drug therapy Lung Neoplasms / drug therapy Azacitidine / therapeutic use Antineoplastic Combined Chemotherapy Protocols / adverse effects
来 源: DOI:10.1016/j.cllc.2023.03.003